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Alessandra Rocchetti, Chris Hawes* and Verena KriechbaumerAbstract
Background: Certain members of the Camelidae family produce a special type of antibody with only one heavy
chain. The antigen binding domains are the smallest functional fragments of these heavy-chain only antibodies and
as a consequence have been termed nanobodies. Discovery of these nanobodies has allowed the development of
a number of therapeutic proteins and tools.
In this study a class of nanobodies fused to fluorescent proteins (chromobodies), and therefore allowing antigen-binding
and visualisation by fluorescence, have been used. Such chromobodies can be expressed in living cells and used as
genetically encoded immunocytochemical markers.
Results: Here a modified version of the commercially available Actin-Chromobody® as a novel tool for visualising actin
dynamics in tobacco leaf cells was tested. The actin-chromobody binds to actin in a specific manner. Treatment with
latrunculin B, a drug which disrupts the actin cytoskeleton through inhibition of polymerisation results in loss of
fluorescence after less than 30 min but this can be rapidly restored by washing out latrunculin B and thereby allowing
the actin filaments to repolymerise.
To test the effect of the actin-chromobody on actin dynamics and compare it to one of the conventional labelling
probes, Lifeact, the effect of both probes on Golgi movement was studied as the motility of Golgi bodies is largely
dependent on the actin cytoskeleton. With the actin-chromobody expressed in cells, Golgi body movement was slowed
down but the manner of movement rather than speed was affected less than with Lifeact.
Conclusions: The actin-chromobody technique presented in this study provides a novel option for in vivo labelling of
the actin cytoskeleton in comparison to conventionally used probes that are based on actin binding proteins.
The actin-chromobody is particularly beneficial to study actin dynamics in plant cells as it does label actin without
impairing dynamic movement and polymerisation of the actin filaments.
Keywords: Actin, Nanobody, Chromobody, Golgi body, Actin dynamicsBackground
Expression and applications of antibody constructs
In 1989, a novel type of antibody was identified first in
the sera of dromedaries and later on in various members
of the Camelidae family [1]. These antibodies differ from
the typical antibody composition of two heavy and two
light chains in that they are composed of just one heavy
chain. Camelids produce both conventional and heavy-
chain only antibodies (HcAbs) in ratios differing by spe-
cies; 45% of llama serum antibodies are HcAbs and 75%
in camels [1]. Isolation of the antigen binding domain
(VHH, variable heavy chain of a heavy-chain antibody),* Correspondence: chawes@brookes.ac.uk
Biological and Medical Sciences, Oxford Brookes University, Oxford OX3 0BP, UK
© 2014 Rocchetti et al.; licensee BioMed Cent
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reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.the smallest functional fragment of these heavy-chain
only antibodies, called nanobodies, lead to the develop-
ment of various therapeutic proteins and tools.
Antibodies have the potential to bind to and therefore
detect any molecule and cell structure making them a
powerful research tool. Nanobodies only have a molecu-
lar mass of around 13 kDa and a size of 2 nm × 4 nm
[2,3]. This small size offers several advantages over con-
ventional antibodies or even antibody fragments such as
monovalent antibody fragments (Fab) and single-chain
variable fragments (scFv). For instance, for expression
studies, only one protein domain has to be cloned and
expressed. Nanobodies also show high stability and solu-
bility even at high temperatures and under denaturing
conditions [4,5]. Due to their stable and soluble nature,ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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heterologous systems in a reproducible manner and such
features also allow for fusions to fluorescent proteins or
protein tags [6]. Specific nanobodies can be screened for in
a phage display system [7]. Nanobodies have been shown
to be produced and functional in cellular compartments
and environments that do not allow formation of disul-
phide bonds and are therefore functional in living cells [8].
In contrast to the flat or concave antigen binding site of
conventional antibodies nanobodies display a convex con-
formation [9,3], allowing binding into otherwise inaccess-
ible clefts and pockets which has proven a useful tool for
inhibiting specific molecules such as lysozyme enzymes [9].
Furthermore, nanobodies still show binding affinities, like
scFvs, in the nanomolar or even picomolar range [5].
Nanobodies have been used and tested in various ap-
plications. For instance they are considered for inhibitory
therapeutic applications against viruses such as Influenza
A, Respiratory Syncytial virus and Rabies virus [10] or
even HIV-1 [11,12] to name a few [reviewed in 13].
A growing tool for manipulating animal and plant sys-
tems is the use of antibodies not only for inhibiting but
altering the function of molecules. Nanobodies are the
system of choice for such due to their ability to function
intracellularly. In potatoes it was shown that they can
target to the correct organelle and inhibit the function of
the potato starch branching enzyme A more efficiently
than an antisense construct [14]. A recent application of
nanobodies has been the detection of the castor bean plant
toxin ricin, a notorious bioterrorism agent. The nanobo-
dies not only show high sensitivity towards ricin but also
high specificity in distinguishing ricin from the non-toxic
castor bean protein RCA120 [15].
The class of biomarkers used in this study have been
termed “chromobodies” as they consist of nanobodies fused
to fluorescent proteins generating fluorescent antigen-
binding nanobodies that can be expressed in living cells
[16]. Chromobodies have been shown to be useful tools
in the real-time detection of dynamic changes in chro-
matin, nuclear lamina and the cytoskeleton in animal
cells [16]. Such fusions have been shown to label and
visualise endogenous cellular structures without dis-
turbing cellular functions allowing real time studies of
live cells processes [16].
Actin cytoskeleton
The actin-cytoskeleton in animal cells is central to cell
shaping, polarity and motility [17]. Most, but not all, plant
cells contain a vacuole occupying up to 90% of the intercel-
lular volume and are caged into a rigid cell wall limiting
the cell expansion [18]. The cytoplasm is therefore con-
strained to a thin layer at the cell cortex and the actin-
cytoskeleton sustains both the organisation of the cortical
endomembrane system and cytoplasmic streaming [19,20].The actin cytoskeleton is a network composed of fine
7 nm diameter filaments that can form bundles. It is
continuously rearranging and actin dynamics have been
described according to a stochastic model: filaments rap-
idly elongate at the barbed end, change shape, slide one
along the other to bundle and finally break down [21].
Actin bundles and fine filaments have different fluores-
cence intensity when labelled as well as differences in re-
sistance to depolymerising agents and dynamics. Bundles
are brighter, more stationary over time and depolymerise
more slowly; the latter have faint fluorescence, are more
dynamic and can depolymerise rapidly [22].
Different labelling strategies have been developed to
study the organisation and dynamics of actin filaments
in plants. The expression of fluorescent actin has not
proved useful in plants because most of it stays in mono-
meric form and diffuse in the cytoplasm resulting in a
strong fluorescent background [23]. Phalloidin, a toxin
extracted from death cup Amanita phalloides, binds
and stabilizes F-actin and when conjugated to the fluores-
cent dye rhodamine selectively stains actin filaments in
permeabilised and fixed plant cells. Rhodamine-phalloidin
staining is also effective in unfixed cells but favours the
formation of bundles [24]. As such it is not useful for any
study of actin dynamics.
Actin binding proteins (ABPs) are involved in regulating
the assembly of actin filaments and therefore are good
marker candidates [25]. The actin binding domain of dif-
ferent ABPs have been fused to fluorescent proteins and
expressed in plants. Lifeact, the most recently developed
probe, is a 17 amino acid peptide from the yeast protein
Abp140 that decorates F-actin [26]. In Arabidopsis thali-
ana Lifeact fused to the fluorescent protein Venus affects
the reorganisation rate of bundles and cytoplasmic strands
of the actin cytoskeleton at higher expression levels but
has proven to be most valuable at optimised lower expres-
sion levels as it is currently the best probe to labels
dynamic populations of actin filaments [27]. The actin
binding domain of mouse talin fused to fluorescent
proteins has been used to label plant actin filaments
but has severe effects on the actin cytoskeleton and its
depolymerisation [28]. One of the two actin-binding do-
mains of the A. thaliana fimbrin1 protein (AtFIM1) fused
to GFP (GFP-fABD2) labels the fine actin dynamic scaf-
fold in different species and cell types. Stable expression
in A. thaliana did not show adverse effects on general
morphology or development [29].
All of the fluorescent reporters available so far depict
varying organisations of the actin network. This may be
due to a preferential binding to fine actin filaments rather
than bundles or because the marker is derived from an
actin-bundling protein therefore causing the aggregation
of actin filaments. Considering that the actin cytoskeleton
is a continuously re-arranging scaffold that provides tracks
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bodies [30], a more reliable and less interfering fluorescent
marker is needed for in vivo imaging.
In this study we used a modified version of the
commercially available Actin-Chromobody® (ChromoTek,
Martinsried, Germany) as a novel tool for visualising actin
dynamics in tobacco leaf cells. The originally supplied plas-
mid contains the 13 kDa actin-binding alpaca VHH fused
to a C-terminal GFP protein. This chromobody was
previously used to transfect HeLa cells to show the re-
covery of the actin filaments after Cytochalasin D treat-
ment (ChromoTek homepage) where it was shown that
the transient binding does not influence cell viability or
motility.
Results and discussion
In planta expression of the actin-chromobody
Constructs fusing the antibody sequence with both N-
and C-terminal fluorescent protein tags, respectively, wereFigure 1 Transient expression of the actin-chromobody. Lane 1) Trans
C-terminal YFP-fusion in Nicotiana tabacum leaves (A); co-expression with t
Lane 2) Transient expression of the actin-chromobody (actin-Cb) construct
Agrobacterium concentrations: OD600 = 0.1 (A), OD600 = 0.0.5 (B), OD600 = 0
actin-chromobody) after 15 in (A), 30 min (B) and (45 min (C) treatment w
cytoskeleton by washing out the LatB after 30 min (A), 45 min (B) and 60prepared. Agrobacterium tumefaciens was transformed with
these constructs and Nicotiana tabacum leaves were infil-
trated with the transformed agrobacteria, either singly or
with the Golgi marker consisting of the signal anchor
sequence of a rat sialyl transferase fused to GFP [ST-
GFP, 31] as described in [32]. In mammalian cells the
C-terminal fusion expressed and actin targeting of the
chromobody was reported (http://www.chromotek.com/
products/chromobodies/actin-chromobody), whereas in
plant cells the antibody C-terminal fusion remained cyto-
solic (Figure 1, lane 1A) with no fluorescence in other or-
ganelles such as the endoplasmic reticulum (Figure 1, lane
1B) but was found in the nucleoplasm (Figure 1, lane 1C),
which is common for cytosolic proteins [33]. The N-
terminal YFP-fusion, however, clearly labelled actin fila-
ments in a specific manner (Figure 1, lane 2A-C).
To determine optimal expression conditions that would
allow investigation of actin dynamics as well as provide
sufficient expression levels for visualisation, tobacco leavesient expression of the actin-chromobody (Actin-Cb) construct with a
he endoplasmic reticulum marker HDEL fused to GFP is shown (B, C).
with an N-terminal YFP-fusion in Nicotiana tabacum leaves at different
.01 (C). Lane 3) Depolymerisation of actin cytoskeleton (labelled by the
ith 25 μM latrunculin B (LatB). Lane 4) Repolymerisation of the actin
min (C), respectively.
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Agrobacterium tumefaciens: OD600 of 0.1, 0.05 and 0.01
with 0.1 being the conventional infiltration OD. The highest
OD of 0.1 resulted in major bundling of actin filaments
(Figure 1, lane 2A) and at the lowest OD of 0.01 the con-
struct mainly bound to thicker actin bundles (Figure 1,
lane 2C). The OD of 0.05 labelled both thicker filaments
as well as finer ones (Figure 1, lane 2B) and was there-
fore chosen for follow-up experimentation. In general at
OD 0.05 what appeared to be a more complete overview
of the actin cytoskeleton with thick bundles and thinner
filaments was obtained compared to that with Lifeact
expression (Figure 2B). On coexpression with the ST-GFP
Golgi marker, Golgi bodies could clearly be seen to be
associated with the actin filament bundles as previously
reported [31].
To investigate if actin dynamics was impaired by the
chromobody binding leaf segments were treated with
25 μM latrunculin B (LatB), an agent isolated from a Red
Sea sponge known to disrupt the actin cytoskeleton of cells.
LatB binds monomeric actin with 1:1 stoichiometry and
thereby blocks F-actin polymerisation without affecting cell
viability [34]. After 15 min of LatB treatment the thinner
strands were completely absent (Figure 1 lane 3A) and after
30 min and 45 min only the bundled actin strands were
visible (Figure 1 lane 3B, C); these bundles remain even
with overnight treatment in the drug (data not shown).
With LatB being a relatively small molecule of less
than 0.4 kDa it is possible to reverse its effects by im-
mersing the leaf cuttings in water and thereby washing
out the drug and allowing the actin filaments to repoly-
merise. A rapid recovery of filamentous actin within less
than one hour of washing was observed (Figure 1, lane
4B) with a visible increase in strands in 30 min (Figure 1,
lane 4A).
Impact of actin-chromobody labelling on actin function
The motility of Golgi bodies is mainly dependent on the
actin cytoskeleton and treatment with the actin depoly-
merising agent cytochalasin D caused the organelles to
stop moving [35]. However, in vivo labelling of the actin
cytoskeleton might compromise the dynamics of the
organelle changing the organisation of the actin net-
work [27].
In order to compare the effect of Lifeact-GFP and the
YFP-actin-Cb on the movement of Golgi bodies in N.
tabacum, the cytoskeleton markers were transiently coex-
pressed with the Golgi marker ST-GFP (Figure 2A, B) and
compared to the transient expression of ST-GFP only. For
this, the infiltration OD and therefore the expression
levels for Lifeact were chosen for optimal Golgi movement
and as little bundling as possible. Movies were collected
for each combination and analysed with Volocity software
to track Golgi bodies and calculate parameters such asvelocity, displacement rate and meandering index. The
values are represented as Cumulative Distribution Fre-
quency (CDF) and means are normalised against data
from ST-GFP expression alone.
The expression of either the cytoskeleton markers sig-
nificantly slowed the motility of Golgi bodies as described
by their velocity which is the length of the track over time
(Figure 2C). The displacement rate, which is the linear
distance between the initial and final position of the or-
ganelle, was not significantly affected by the expression
of Lifeact-GFP but was significantly reduced in the presence
of YFP-actin-Cb (Figure 2D). Both velocity and displace-
ment rate in the combinations of ST-GFP and YFP-actin-
Cb or Lifeact-GFP, respectively, were normalised to the
datasets for expression of ST-GFP alone and presented as a
percentage of the latter (Figure 2E). The final parameter
assessed was the Meandering Index which is the ratio
between the displacement rate and velocity (the ratio
between the linear distance and the overall path of the
Golgi body), describing the type of Golgi movement.
The closer the meandering index is to a value of 1, the
more directional and linear is the movement. The smaller
the meandering index, the more saltatory is the organelle
movement. The meandering index therefore gives an
indication of the complexity of the dynamics. Upon the
expression of Lifeact-GFP, the relative mean of the mean-
dering index was significantly increased by 19% compared
to ST-GFP alone indicating that the organelles moved more
uni-directionally (Figure 2E). YFP-actin-Cb significantly
reduced the meandering index by 11% with respect to
ST-GFP (Figure 2E) indicating that the saltatory movement
was slightly favoured. The emerging model (Figure 2F) is
that given a fixed time span of 1 second Golgi bodies move
more slowly, with a shorter linear distance but conserve
the complexity of the movement pattern in the presence of
the antibody. Coexpression with Lifeact-GFP results in a
reduction of the velocity, with the same linear distance but
a much less saltatory movement.
These effects of the markers on actin dynamics might
be explained by the different effects the two markers
have on cytoskeleton rearrangement and thus its dy-
namic. Lifeact derives from a cross bundling factor and
favours the formation of actin cables that might lead
Golgi bodies along more directional pathways whilst
binding of the actin-Cb might interfere less with the fila-
ment organisation therefore having a less of an effect on
the movement type.
Conclusion
Mainly due to their small size and stability in combin-
ation with production advantages, nanobodies have been
shown to be valuable tools for inhibiting or manipulating
cell processes with a great potential for genetically encoded
in vivo immunocytochemical labelling.
Figure 2 (See legend on next page.)
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Figure 2 Golgi movement and actin cytoskeleton dynamics. A) Transient co-expression of the actin-chromobody (YFP-actin-Cb in yellow)
construct with the Golgi marker ST-GFP (green dots); B) co-expression of Lifeact GFP (green lines) with ST-GFP (green dots). Scale bars = 5 μm.
Cumulative Distribution Frequency (CDF) plots of velocity (C) and displacement rate (D) of N. tabacum transiently expressing only ST-GFP (blue line),
both ST-GFP and YFP-actin-Cb (yellow line) or ST-GFP and Lifeact-GFP (green line), respectively. Curves marked with shapes (*, ♦) indicate a statistically
significant difference from the control ST-GFP of p < 0.05. E) Velocity, displacement rate and meandering index values calculated with Volocity software
for N. tabacum transiently expressing ST-GFP (blue line), both ST-GFP and YFP-actin-Cb (yellow line) or ST-GFP and Lifeact-GFP (green line), respectively.
Mean values are expressed as a percentage of the control (ST-GFP). Symbols (*, ♦,▲) indicate that the means are significantly different from the
control at p < 0.05. F) Schematic representation of the path and movement pattern of Golgi bodies. When ST-GFP is coexpressed with Lifeact-GFP,
Golgi bodies move same linear distance as the control but have a less salutatory path. The coexpression of the antibody determines Golgi bodies
moving shorter linear distance and slightly more salutatory.
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useful for the study of actin dynamics in plant cells as it
labels the actin, but does not overall impair the pattern
of organelle movement, although it does slow organelle
velocity. It is thus another option for in vivo labelling of
actin compared with the commonly used fluorescent
protein probes based around actin binding proteins or
their active domains. It may be possible to exploit the re-
duction in organelle movement and by implication myosin
activity, for the study of organelle dynamics and their rela-
tionship with the actin cytoskeleton.
Methods
Cloning of expression plasmids
The Actin-Chromobody® plasmid containing the al-
paca actin-antibody gene was obtained from Chromo-
Tek (Martinsried, Germany). Primers were ordered from
Eurofins MWG Operon (Ebersberg, Germany). Q5 high-
fidelity DNA polymerase (New England Biolabs, Herts,
UK) was used for all polymerase chain reaction (PCR)
reactions. The actin-Ab-PCR product was cloned into
the binary vectors PB7WGY2 and PB7YWG2 providing
an N- or C-terminal YFP-tag, respectively, using Gateway®
technology (Invitrogen life sciences).
Plant material and transient expression system
For Agrobacterium-mediated transient expression, 4-week-
old tobacco (Nicotiana tabacum SR1 cv Petit Havana)
plants grown in the greenhouse were used. Briefly, each ex-
pression vector was introduced into Agrobacterium strain
GV3101 (pMP90) by heat shock. A single colony from the
transformants was inoculated into 5 ml of YEB medium
(per litre: 5 g of beef extract, 1 g of yeast extract, 5 g of
sucrose and 0.5 g of MgSO4·7H2O) supplemented with
50 μg/ml spectinomycin and rifampicin. After overnight
shaking at 25°C, 1 ml of the bacterial culture was pel-
leted in a 1.5-ml tube by centrifugation at 2200 × g for
5 min at room temperature. The pellet was washed
twice with 1 ml of infiltration medium (50 mM MES,
2 mM Na3PO4·12H2O, 0.1 mM acetosyringone and
5 mg/ml glucose) and then resuspended in 1 ml of infil-
tration buffer. The bacterial suspension was diluted withthe same buffer to adjust the inoculum concentration to
the desired final OD600 (0.1, 0.05 or 0.01) for YFP-actin-
Cb and OD600 = 0.01 for Lifeact-GFP and inoculated
using a 1 ml syringe without a needle by gentle pressure
through the stomata on the lower epidermal surface. For
experiments requiring co-infection of more than one con-
struct, bacterial strains containing the constructs were
mixed prior to the leaf infiltration, with the inoculum of
each mixed construct adjusted to the required final OD600.
Transformed plants then were incubated under normal
growth conditions for 48 h.
Images were taken using a Zeiss LSM510 Meta laser
scanning confocal microscope (http://www.zeiss.com/) with
40× and 63× oil immersion objectives. For imaging of GFP/
YFP combinations, samples were excited using 458 and
514 nm laser lines in multi-track mode with line switching.
Images were edited using the LSM510 image browser and
Adobe Photoshop.
Microscopy and movies
For dual imaging 488 nm excitation and 505-530 band
pass filters were used for eGFP and for YFP an excita-
tion of 514 nm and BP 470-500 was used; dual imaging
of GFP and YFP was captured as described above.
Movies were acquired using 63X objective lens, zoomed
to ×3.7 and a ROI of 244 × 244 pixels. Movies of 50
frames were acquired at scan time of 470 msec. Example
movie files used for this analysis are shown in Additional
file 1.
Organelle tracking and statistical analysis
Organelle tracking was done using the Volocity 6.3
(Improvision - PerkinElmer). Intensity and size parameters
were set and the software identified and tracked Golgi
bodies according to shortest path model. The velocity,
displacement rate and meandering index of 100-344 Golgi
bodies per condition were calculated by the software.
Statistical analysis and graphs were done with SPSS
21.0 and the Kolmogorov-Smirnov test was used to
assess the statistical difference in the distribution of
velocity, displacement rate and meandering index values
for p < 0.05.
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Additional file 1: Example movies of Golgi body movement.
Movement of Golgi bodies (ST-GFP labelled, green dots) in co-expression
with YFP-actin-Cb (A) or Lifeact-GFP (B), respectively. Green fluorescent
(Golgi) dots in movies were analysed with the Volocity software to calculate
velocity, displacement rate and meandering index of Golgi body movement.
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